Bioworkshops sell "Cilgavimab"
Basic Information
846
23
15
4.3(7)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Cilgavimab
Manufacturer(s)
Specifications
- Regulatory Status: US-approved (2021-12-08); developed from DMF-filed cell line for global regulatory readiness
- Application: SARS-CoV-2 spike-protein monoclonal antibody for COVID-19/respiratory disease treatment
- Expression System: Optimized high-titer mammalian cell line/process for large-scale mAb production
Documents
GMP
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment